Adam Sutherland

696 total citations
29 papers, 390 citations indexed

About

Adam Sutherland is a scholar working on Emergency Medical Services, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Adam Sutherland has authored 29 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Emergency Medical Services, 12 papers in Geriatrics and Gerontology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Adam Sutherland's work include Patient Safety and Medication Errors (16 papers), Pharmaceutical Practices and Patient Outcomes (12 papers) and Pharmaceutical studies and practices (8 papers). Adam Sutherland is often cited by papers focused on Patient Safety and Medication Errors (16 papers), Pharmaceutical Practices and Patient Outcomes (12 papers) and Pharmaceutical studies and practices (8 papers). Adam Sutherland collaborates with scholars based in United Kingdom, United States and France. Adam Sutherland's co-authors include Darren M. Ashcroft, Anwar A. Alghamdi, Richard N. Keers, Denham L. Phipps, Stephen Tomlin, David Ellis, Stephen Waldek, Stavros Petrou, Andrew McKay and Angela Boland and has published in prestigious journals such as Archives of Disease in Childhood, British Journal of Clinical Pharmacology and Health Technology Assessment.

In The Last Decade

Adam Sutherland

27 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Sutherland United Kingdom 9 212 146 117 70 46 29 390
Jared Cash United States 11 184 0.9× 104 0.7× 158 1.4× 127 1.8× 67 1.5× 20 522
Carol Taketomo United States 6 199 0.9× 126 0.9× 169 1.4× 75 1.1× 50 1.1× 9 502
Carla Meyer‐Massetti Switzerland 10 137 0.6× 226 1.5× 37 0.3× 74 1.1× 49 1.1× 46 524
Judy L. Smetzer United States 10 197 0.9× 120 0.8× 53 0.5× 62 0.9× 54 1.2× 77 389
Rachel Kruer United States 10 74 0.3× 69 0.5× 40 0.3× 41 0.6× 20 0.4× 33 309
Manuel Vélez‐Díaz‐Pallarés Spain 11 78 0.4× 215 1.5× 51 0.4× 40 0.6× 10 0.2× 47 437
Caroline Fonzo‐Christe Switzerland 11 70 0.3× 84 0.6× 136 1.2× 32 0.5× 27 0.6× 28 349
Ray R. Maddox United States 10 164 0.8× 72 0.5× 47 0.4× 149 2.1× 90 2.0× 21 421
Micheline Jacquet France 7 297 1.4× 228 1.6× 76 0.6× 50 0.7× 9 0.2× 9 444
Margaret M. Verrico United States 10 112 0.5× 106 0.7× 37 0.3× 69 1.0× 24 0.5× 14 323

Countries citing papers authored by Adam Sutherland

Since Specialization
Citations

This map shows the geographic impact of Adam Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Sutherland more than expected).

Fields of papers citing papers by Adam Sutherland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Sutherland. The network helps show where Adam Sutherland may publish in the future.

Co-authorship network of co-authors of Adam Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Sutherland. A scholar is included among the top collaborators of Adam Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Sutherland. Adam Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutherland, Adam, Denham L. Phipps, Stephen Tomlin, et al.. (2025). ‘They Take the Mum Off You When You Come In’: An Ethnographic Study of Parent Experiences of Medicines Safety Systems in English Hospitals. Health Expectations. 28(1). e70161–e70161. 1 indexed citations
2.
Sutherland, Adam, Denham L. Phipps, Suzanne Grant, et al.. (2024). Understanding the informal aspects of medication processes to maintain patient safety in hospitals: a sociotechnical ethnographic study in paediatric units. Ergonomics. 68(3). 444–458. 1 indexed citations
3.
Sutherland, Adam, Denham L. Phipps, A. Malcolm Gill, Stephen Morris, & Darren M. Ashcroft. (2023). Medication Safety Gaps in English Pediatric Inpatient Units: An Exploration Using Work Domain Analysis. Journal of Patient Safety. 20(1). 7–15. 2 indexed citations
4.
5.
Alghamdi, Anwar A., Richard N. Keers, Adam Sutherland, Andrew Carson‐Stevens, & Darren M. Ashcroft. (2021). A Mixed-Methods Analysis of Medication Safety Incidents Reported in Neonatal and Children’s Intensive Care. Pediatric Drugs. 23(3). 287–297. 9 indexed citations
6.
Alghamdi, Anwar A., Richard N. Keers, Adam Sutherland, et al.. (2021). Incidence and nature of adverse drug events in paediatric intensive care units: A prospective multicentre study. British Journal of Clinical Pharmacology. 88(5). 2213–2222. 2 indexed citations
7.
Sutherland, Adam, et al.. (2020). P54 Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review. Archives of Disease in Childhood. 105(9). e35.1–e35.
8.
Alghamdi, Anwar A., Richard N. Keers, Adam Sutherland, & Darren M. Ashcroft. (2019). Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review. Drug Safety. 42(12). 1423–1436. 105 indexed citations
9.
Sutherland, Adam, Denham L. Phipps, Stephen Tomlin, & Darren M. Ashcroft. (2019). Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review. BMC Pediatrics. 19(1). 486–486. 36 indexed citations
10.
Sutherland, Adam, Darren M. Ashcroft, & Denham L. Phipps. (2019). Exploring the human factors of prescribing errors in paediatric intensive care units. Archives of Disease in Childhood. 104(6). 588–595. 33 indexed citations
11.
Harris, David, et al.. (2018). A national scoping survey of standard infusions in paediatric and neonatal intensive care units in the United Kingdom. Journal of Pharmacy and Pharmacology. 70(10). 1324–1331. 12 indexed citations
12.
Broomfield, Alexander, Jean Mercer, Heather J. Church, et al.. (2017). Combined therapeutic approach to protein losing enteropathy complicating type 3 Gaucher disease using eliglustat. Molecular Genetics and Metabolism. 120(1-2). S32–S32. 1 indexed citations
13.
Sutherland, Adam, et al.. (2016). ASSESSING PHARMACEUTICAL CARE NEEDS OF PAEDIATRIC IN-PATIENTS: A TEAM BASED APPROACH. Archives of Disease in Childhood. 101(9). e2.34–e2. 3 indexed citations
14.
Sutherland, Adam, et al.. (2016). PROLONGED INFUSIONS OF KETAMINE AND IMPACT ON INFECTIONS AND WASTE. Archives of Disease in Childhood. 101(9). e2.4–e2. 1 indexed citations
15.
Sutherland, Adam, et al.. (2016). THE IMPACT OF FIXED CONCENTRATIONS SEDATION INFUSIONS ON FLUID OVERLOAD IN CRITICALLY ILL CHILDREN. Archives of Disease in Childhood. 101(9). e2.43–e2. 1 indexed citations
16.
Sutherland, Adam, et al.. (2016). CHANGING INFUSION PRACTICE GENERATES SIGNIFICANT EFFICIENCIES IN NURSING TIME AND RESOURCE USAGE IN PAEDIATRIC INTENSIVE CARE. Archives of Disease in Childhood. 101(9). e2.16–e2. 1 indexed citations
17.
Sutherland, Adam & Stephen Waldek. (2015). It is time to review how unlicensed medicines are used. European Journal of Clinical Pharmacology. 71(9). 1029–1035. 15 indexed citations
18.
19.
Sutherland, Adam, et al.. (2014). THE IMPACT OF EVIDENCE-BASED INTERVENTIONS ON REDUCING PRESCRIBING ERRORS IN PICU. Archives of Disease in Childhood. 99(8). e3–e3. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jared Cash Breakdown of academic impact, for papers by Carol Taketomo Breakdown of academic impact, for papers by Carla Meyer‐Massetti Breakdown of academic impact, for papers by Judy L. Smetzer Breakdown of academic impact, for papers by Rachel Kruer Breakdown of academic impact, for papers by Manuel Vélez‐Díaz‐Pallarés Breakdown of academic impact, for papers by Caroline Fonzo‐Christe Breakdown of academic impact, for papers by Ray R. Maddox Breakdown of academic impact, for papers by Micheline Jacquet Breakdown of academic impact, for papers by Margaret M. Verrico
Rankless by CCL
2026